About Biosensors & Diagnostics
The Biosensors & Diagnostics category is part of the Synthetic Biology market map, tracking 12 companies building in this segment. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. Curated by Hartmann Capital's venture research team.
Companies in Biosensors & Diagnostics
- Sherlock Biosciences — Series B, $115M
- Detect — Series B, $113M
- Viridos — Series C, $125M
- Sense Biodetection — Acquired
- Stemloop — Seed, $12M
- Tangen Biosciences — Series A, $6M
- Biomeme — Series B, $30M
- Cardea Bio — Acquired, $21M
- Genalyte — Series C, $98M
- GnuBIO — Acquired
- Miroculus — Series B, $32M
- Volta Labs — Series A, $21M
Frequently Asked Questions
- What companies are in the Biosensors & Diagnostics category?
- The Biosensors & Diagnostics category includes 12 companies: Sherlock Biosciences, Detect, Viridos, Sense Biodetection, Stemloop, Tangen Biosciences, Biomeme, Cardea Bio, Genalyte, GnuBIO, Miroculus, Volta Labs. This is part of the Synthetic Biology market map maintained by Hartmann Capital.
- How many Biosensors & Diagnostics startups are tracked?
- Hartmann Capital tracks 12 companies in the Biosensors & Diagnostics segment of the Synthetic Biology market map.
- What are the best funded Biosensors & Diagnostics companies?
- Top funded companies in Biosensors & Diagnostics include Viridos ($125M), Sherlock Biosciences ($115M), Detect ($113M), Genalyte ($98M), Miroculus ($32M). Browse the full list in the Synthetic Biology market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.